Clark Bobby L, Hou John, Chou Chia-Hung, Huang Elbert S, Conti Rena
Bobby L. Clark (
John Hou is manager of outcomes and health services research at Walgreens.
Health Aff (Millwood). 2014 Nov;33(11):2012-7. doi: 10.1377/hlthaff.2014.0833.
Section 340B of the Public Health Service Act provides qualified organizations serving vulnerable populations with deep discounts for some outpatient medications. A 2010 regulatory change widely expanded the 340B program's reach, allowing these organizations to contract with retail pharmacies to dispense medications for eligible patients. Little is known about which medications are dispensed by contract pharmacies under the expanded program. We provide the first comparison of 340B prescriptions and all prescriptions dispensed in contract pharmacies. We used 2012 data from Walgreens, the national leader in 340B contract pharmacies. Medications used to treat chronic conditions such as diabetes, high cholesterol levels, asthma, and depression accounted for an overwhelming majority of all prescriptions dispensed at Walgreens as part of the 340B program. A higher percentage of antiretrovirals used to treat HIV/AIDS were dispensed through 340B prescriptions than through all prescriptions dispensed at Walgreens. The majority of 340B prescriptions dispensed at Walgreens originated at tuberculosis clinics, consolidated health centers, disproportionate-share hospitals, and Ryan White clinics. Our results suggest that 340B contract pharmacies dispense medications used to treat Americans' chronic disease burden and disproportionately dispense medications used by key vulnerable populations targeted by the program.
《公共卫生服务法》第340B条规定,为弱势群体提供服务的合格组织可享受部分门诊药物的大幅折扣。2010年的一项监管变革大幅扩大了340B计划的覆盖范围,允许这些组织与零售药店签约,为符合条件的患者配药。对于在扩大后的计划下,合同药店配销哪些药物,人们知之甚少。我们首次对340B处方与合同药店配销的所有处方进行了比较。我们使用了沃尔格林(Walgreens)2012年的数据,该公司是340B合同药店的全国领先者。作为340B计划的一部分,用于治疗糖尿病、高胆固醇、哮喘和抑郁症等慢性病的药物在沃尔格林配销的所有处方中占绝大多数。通过340B处方配销的用于治疗艾滋病毒/艾滋病的抗逆转录病毒药物的比例高于沃尔格林配销的所有处方。在沃尔格林配销的大多数340B处方来自结核病诊所、综合健康中心、高比例分担医院和瑞安·怀特诊所。我们的结果表明,340B合同药店配销用于治疗美国人慢性病负担的药物,并且不成比例地配销该计划所针对的主要弱势群体使用的药物。